FINWIRES · TerminalLIVE
FINWIRES

Canada's Parliamentary Watchdog Has Examined the Fed Govt's Expenditure Plan and Main Estimates For 2026-27

By

-- The Parliamentary Budget Office (PBO) Thursday said it examined the Canadian federal government's Expenditure Plan and Main Estimates for 2026-27, which supports the appropriation bill that seeks lawmakers' approval of $230.4 billion in budgetary authorities.

Parliament has already provided legislative authority for most of the planned spending ($272.4 billion) for the 2026-27 fiscal year through other pieces of legislation, the PBO noted.

Among highlights, PBO noted the Canada Health Transfer is set to increase by $2.7 billion (5%) to $57.4 billion in 2026-27; and Federal spending on Elderly Benefits is set to rise by $5.7 billion (6.9%) to a total of $88.8 billion in 2026-27. However, PBO said, after tabling of the Main Estimates, the government released its Spring Economic Update 2026, which now forecasts Elderly Benefits to cost 89.3 billion for 2026-27 (a lift of $6.9 billion or 7.6%).

In other highlights, the 2026-27 Main Estimates outline $53.7 billion in forecasted statutory authorities related to servicing public debt, which represents a $4.7 billion increase (9.5%) from the 2025-26 Estimates to date for the preceding year, and includes $48.6 billion for interest on unmatured debt and $5.1 billion for other interest costs.

PBO noted Main Estimates include $14.7 billion in funding for Budget 2025 measures. Also, initiatives related to Rebuilding, Rearming, and Reinvesting in the Canadian Armed Forces represent 71.1% of Budget 2025 proposed spending in these Estimates, including $9 billion to the Department of National Defence (DND) and $675.3 million to the Communications Security Establishment Canada (CES).

Related Articles

Mining & Metals

RBC Maintains Suncor Energy's Outperform Rating, C$100 Price Target

RBC Capital Markets on Wednesday reiterated Suncor Energy's (SU.TO) outperform rating and C$100 price target, with the bank noting the company delivered another quarter of "robust performance" punctuated by a "jumbo-sized" downstream pre-tax margin of $2 billion (including FIFO gains) in part driven by record refined product sales of 680,900 bbl/d.RBC's updated production outlook of 862,100 bbl/d, anchored by a $5.7 billion capital program, remains relatively unchanged."Suncor's first-quarter results reinforced our confidence that its culture of sustained high performance is taking deep root and enabling the company to be on the podium, come what may," RBC said. "We believe the ingredients are in place for the company to earn a premium relative valuation, conceivably over the next year," RBC added.Suncor is RBC's favorite integrated producer in Canada and is part of its Global Energy Best Ideas list.Suncor traded at $85.70 per share at last look Thursday on the Toronto Stock Exchange.Price: $85.70, Change: $-2.21, Percent Change: -2.51%

$SU.TO
Australia

RBC Capital Adjusts VSE Price Target to $240 From $220, Maintains Outperform Rating

VSE (VSEC) has an average rating of Buy and mean price target of $248.50, according to analysts polled by FactSet.Price: $206.85, Change: $-0.60, Percent Change: -0.29%

$VSEC
Australia

RBC Capital Adjusts United Therapeutics Price Target to $701 From $707, Maintains Outperform Rating

United Therapeutics (UTHR) has an average rating of buy and mean price target of $670.67, according to analysts polled by FactSet.Price: $585.63, Change: $-11.14, Percent Change: -1.87%

$UTHR